{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:47:39Z","timestamp":1788385659856,"version":"build-2803163510"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.exer.2024.109931","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T16:35:58Z","timestamp":1715963758000},"page":"109931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Efficient retinal ganglion cells transduction by retro-orbital venous sinus injection of AAV-PHP.eB in mature mice"],"prefix":"10.1016","volume":"244","author":[{"given":"Mingjun","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuxueying","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifeng","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaijing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meifang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.exer.2024.109931_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte-endothelial interactions at the blood-brain barrier","volume":"7","author":"Abbott","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"issue":"24","key":"10.1016\/j.exer.2024.109931_bib2","doi-asserted-by":"crossref","first-page":"15238","DOI":"10.1128\/JVI.79.24.15238-15245.2005","article-title":"Novel caprine adeno-associated virus (aav) capsid (Aav-Go.1) is closely related to the primate aav-5 and has unique tropism and neutralization properties","volume":"79","author":"Arbetman","year":"2005","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.exer.2024.109931_bib3","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1167\/iovs.15-17994","article-title":"Sox2-Deficient m\u00fcller glia disrupt the structural and functional maturation of the mammalian retina","volume":"57","author":"Bachleda","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"21","key":"10.1016\/j.exer.2024.109931_bib4","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","article-title":"Effect of gene therapy on visual function in leber's congenital Amaurosis","volume":"358","author":"Bainbridge","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.exer.2024.109931_bib5","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa1414221","article-title":"Long-term effect of gene therapy on leber's congenital Amaurosis","volume":"372","author":"Bainbridge","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.exer.2024.109931_bib6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/hum.2006.17.601","article-title":"Intrahepatic injection of recombinant adeno-associated virus serotype 2 overcomes gender-related differences in liver transduction","volume":"17","author":"Berraondo","year":"2006","journal-title":"Hum. Gene Ther."},{"issue":"4","key":"10.1016\/j.exer.2024.109931_bib7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ymthe.2004.07.016","article-title":"Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6","volume":"10","author":"Blankinship","year":"2004","journal-title":"Mol. Ther."},{"issue":"22","key":"10.1016\/j.exer.2024.109931_bib8","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/sj.gt.3303029","article-title":"Systemic aav-9 transduction in mice is influenced by animal age but not by the route of administration","volume":"14","author":"Bostick","year":"2007","journal-title":"Gene Ther."},{"issue":"3\u20134","key":"10.1016\/j.exer.2024.109931_bib9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41434-019-0060-0","article-title":"Factors governing the transduction efficiency of adeno-associated virus in the retinal ganglion cells following intravitreal injection","volume":"26","author":"Cao","year":"2019","journal-title":"Gene Ther."},{"issue":"7","key":"10.1016\/j.exer.2024.109931_bib10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1089\/hum.2017.154","article-title":"Synthetic adeno-associated viral vector efficiently targets mouse and nonhuman primate retina in vivo","volume":"29","author":"Carvalho","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.exer.2024.109931_bib11","first-page":"1771","article-title":"Glycosidic enzymes enhance retinal transduction following intravitreal delivery of Aav2","volume":"17","author":"Cehajic-Kapetanovic","year":"2011","journal-title":"Mol. Vis."},{"issue":"8","key":"10.1016\/j.exer.2024.109931_bib12","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.apsb.2020.01.015","article-title":"Gene therapy for neurodegenerative disorders: advances, insights and prospects","volume":"10","author":"Chen","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"9","key":"10.1016\/j.exer.2024.109931_bib13","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1089\/hum.2009.086","article-title":"Human Rpe65 gene therapy for leber congenital Amaurosis: persistence of early visual improvements and safety at 1 year","volume":"20","author":"Cideciyan","year":"2009","journal-title":"Hum. Gene Ther."},{"issue":"5","key":"10.1016\/j.exer.2024.109931_bib14","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/mt.2010.248","article-title":"Anterograde axonal transport of aav2-gdnf in rat basal ganglia","volume":"19","author":"Ciesielska","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.exer.2024.109931_bib15","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ebiom.2016.11.016","article-title":"Phase 2a randomized clinical trial: safety and post hoc analysis of subretinal Raav.Sflt-1 for wet age-related macular degeneration","volume":"14","author":"Constable","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.exer.2024.109931_bib16","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ajo.2017.02.018","article-title":"Gene therapy in neovascular age-related macular degeneration: three-year follow-up of a phase 1 randomized dose escalation trial","volume":"177","author":"Constable","year":"2017","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2024.109931_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.preteyeres.2014.07.001","article-title":"Cellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseases","volume":"43","author":"Cuenca","year":"2014","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2024.109931_bib18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/978-1-4614-3209-8_86","article-title":"Advances in aav vector development for gene therapy in the retina","volume":"801","author":"Day","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.exer.2024.109931_bib19","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nbt.3440","article-title":"Cre-dependent selection yields aav variants for widespread gene transfer to the adult brain","volume":"34","author":"Deverman","year":"2016","journal-title":"Nat. Biotechnol."},{"issue":"7","key":"10.1016\/j.exer.2024.109931_bib20","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/mt.2009.71","article-title":"Intravenous administration of self-complementary Aav9 enables transgene delivery to adult motor neurons","volume":"17","author":"Duque","year":"2009","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.exer.2024.109931_bib21","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-vegf agents: a review of literature","volume":"27","author":"Falavarjani","year":"2013","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.exer.2024.109931_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular Aav9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat. Biotechnol."},{"issue":"10","key":"10.1016\/j.exer.2024.109931_bib23","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1007\/s00417-021-05358-y","article-title":"Characterizing temporal and spatial recruitment of systemically administered rpe65-programmed bone marrow-derived cells to the retina in a mouse model of age-related macular degeneration","volume":"259","author":"Francelin","year":"2021","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2024.109931_bib24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/978-1-4939-9139-6_14","article-title":"Subilm injection of aav for gene delivery to the retina","volume":"1950","author":"Gamlin","year":"2019","journal-title":"Methods Mol. Biol."},{"issue":"10","key":"10.1016\/j.exer.2024.109931_bib25","doi-asserted-by":"crossref","first-page":"6081","DOI":"10.1073\/pnas.0937739100","article-title":"Adeno-associated viruses undergo substantial evolution in primates during natural infections","volume":"100","author":"Gao","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.exer.2024.109931_bib26","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1128\/JVI.78.12.6381-6388.2004","article-title":"Clades of adeno-associated viruses are widely disseminated in human tissues","volume":"78","author":"Gao","year":"2004","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.exer.2024.109931_bib27","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/gt.2016.24","article-title":"Axonal transport of Aav9 in nonhuman primate brain","volume":"23","author":"Green","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.exer.2024.109931_bib28","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3389\/fnins.2017.00521","article-title":"A novel retinal ganglion cell promoter for utility in aav vectors","volume":"11","author":"Hanlon","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.exer.2024.109931_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0079-6123(09)17510-6","article-title":"Gene therapy and transplantation in the retinofugal pathway","volume":"175","author":"Harvey","year":"2009","journal-title":"Prog. Brain Res."},{"issue":"10","key":"10.1016\/j.exer.2024.109931_bib30","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1089\/hum.2008.107","article-title":"Treatment of leber congenital Amaurosis due to Rpe65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial","volume":"19","author":"Hauswirth","year":"2008","journal-title":"Hum. Gene Ther."},{"issue":"1","key":"10.1016\/j.exer.2024.109931_bib31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ymthe.2006.03.014","article-title":"Robust systemic transduction with Aav9 vectors in mice: efficient global cardiac gene transfer superior to that of Aav8","volume":"14","author":"Inagaki","year":"2006","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.exer.2024.109931_bib32","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1073\/pnas.0810682106","article-title":"Efficient gene therapy-based method for the delivery of therapeutics to primate cortex","volume":"106","author":"Kells","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.exer.2024.109931_bib33","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ymthe.2017.09.014","article-title":"Safety and long-term efficacy of Aav4 gene therapy in patients with Rpe65 leber congenital Amaurosis","volume":"26","author":"Le Meur","year":"2018","journal-title":"Mol. Ther."},{"issue":"18","key":"10.1016\/j.exer.2024.109931_bib34","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/sj.gt.3302791","article-title":"Aav-mediated expression of cntf promotes long-term survival and regeneration of adult rat retinal ganglion cells","volume":"13","author":"Leaver","year":"2006","journal-title":"Gene Ther."},{"issue":"4","key":"10.1016\/j.exer.2024.109931_bib35","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1474-4422(11)70039-4","article-title":"Aav2-Gad gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial","volume":"10","author":"LeWitt","year":"2011","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.exer.2024.109931_bib36","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.7150\/ijbs.25996","article-title":"The Nrf2 signaling in retinal ganglion cells under oxidative stress in ocular neurodegenerative diseases","volume":"14","author":"Liu","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.exer.2024.109931_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.107955","article-title":"Longitudinal evaluation of immediate inflammatory responses after intravitreal Aav2 injection in rats by optical coherence tomography","volume":"193","author":"Liu","year":"2020","journal-title":"Exp. Eye Res."},{"issue":"1","key":"10.1016\/j.exer.2024.109931_bib38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11011-020-00630-2","article-title":"Crossing the blood-brain barrier with aav vectors","volume":"36","author":"Liu","year":"2021","journal-title":"Metab. Brain Dis."},{"issue":"9923","key":"10.1016\/j.exer.2024.109931_bib39","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(13)62117-0","article-title":"Retinal gene therapy in patients with choroideremia: initial findings from a phase 1\/2 clinical trial","volume":"383","author":"MacLaren","year":"2014","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.exer.2024.109931_bib40","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","article-title":"Safety and efficacy of gene transfer for leber's congenital Amaurosis","volume":"358","author":"Maguire","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"9701","key":"10.1016\/j.exer.2024.109931_bib41","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(09)61836-5","article-title":"Age-dependent effects of Rpe65 gene therapy for leber's congenital Amaurosis: a phase 1 dose-escalation trial","volume":"374","author":"Maguire","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.exer.2024.109931_bib42","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1046-2023(02)00232-3","article-title":"Gene delivery to the eye using adeno-associated viral vectors","volume":"28","author":"Martin","year":"2002","journal-title":"Methods"},{"issue":"1","key":"10.1016\/j.exer.2024.109931_bib43","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/gt.2013.64","article-title":"Tyrosine capsid-mutant aav vectors for gene delivery to the canine retina from a subretinal or intravitreal approach","volume":"21","author":"Mowat","year":"2014","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.exer.2024.109931_bib44","first-page":"226","article-title":"Pan-retinal ganglion cell markers in mice, rats, and rhesus macaques","volume":"44","author":"Nadal-Nicol\u00e1s","year":"2023","journal-title":"Zool. Res."},{"issue":"1","key":"10.1016\/j.exer.2024.109931_bib45","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1128\/JVI.79.1.214-224.2005","article-title":"Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice","volume":"79","author":"Nakai","year":"2005","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.exer.2024.109931_bib46","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/hum.2005.16.299","article-title":"Modified infusion procedures affect recombinant adeno-associated virus vector type 2 transduction in the liver","volume":"16","author":"Ohashi","year":"2005","journal-title":"Hum. Gene Ther."},{"issue":"4","key":"10.1016\/j.exer.2024.109931_bib47","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1161\/01.RES.0000237661.18885.f6","article-title":"Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo","volume":"99","author":"Pacak","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.exer.2024.109931_bib48","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.omtm.2022.03.016","article-title":"Aav-Php.Eb transduces both the inner and outer retina with high efficacy in mice","volume":"25","author":"Palfi","year":"2022","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"7","key":"10.1016\/j.exer.2024.109931_bib49","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/IAE.0b013e3181a94f01","article-title":"Intravitreal injection of therapeutic agents","volume":"29","author":"Peyman","year":"2009","journal-title":"Retina"},{"issue":"10011","key":"10.1016\/j.exer.2024.109931_bib50","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/S0140-6736(15)00345-1","article-title":"Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 Year follow-up of a phase 1 randomised clinical trial","volume":"386","author":"Rakoczy","year":"2015","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.exer.2024.109931_bib51","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2174\/1570159X15666170724104305","article-title":"Neuroprotection by (Endo)Cannabinoids in glaucoma and retinal neurodegenerative diseases","volume":"16","author":"Rapino","year":"2018","journal-title":"Curr. Neuropharmacol."},{"issue":"9","key":"10.1016\/j.exer.2024.109931_bib52","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.4103\/1673-5374.306063","article-title":"The future of retinal gene therapy: evolving from subretinal to intravitreal vector delivery","volume":"16","author":"Ross","year":"2021","journal-title":"Neural Regen Res"},{"issue":"5","key":"10.1016\/j.exer.2024.109931_bib53","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41434-021-00219-z","article-title":"Rescue of retinal ganglion cells in optic nerve injury using cell-selective aav mediated delivery of Sirt1","volume":"28","author":"Ross","year":"2021","journal-title":"Gene Ther."},{"issue":"6","key":"10.1016\/j.exer.2024.109931_bib54","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ymthe.2005.09.009","article-title":"Identification of mouse aav capsid-specific Cd8+ T cell epitopes","volume":"12","author":"Sabatino","year":"2005","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.exer.2024.109931_bib55","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1089\/hum.2013.005","article-title":"Strong cortical and spinal cord transduction after Aav7 and Aav9 delivery into the cerebrospinal fluid of nonhuman primates","volume":"24","author":"Samaranch","year":"2013","journal-title":"Hum. Gene Ther."},{"issue":"4","key":"10.1016\/j.exer.2024.109931_bib56","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/gt.2017.14","article-title":"Mr-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brain","volume":"24","author":"Samaranch","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.exer.2024.109931_bib57","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-3-030-27378-1_18","article-title":"Systemic delivery of genes to retina using adeno-associated viruses","volume":"1185","author":"Simpson","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"7","key":"10.1016\/j.exer.2024.109931_bib58","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.7150\/thno.42611","article-title":"Focused ultrasound as a novel strategy for noninvasive gene delivery to retinal m\u00fcller glia","volume":"10","author":"Touahri","year":"2020","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.exer.2024.109931_bib59","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/gt.2011.151","article-title":"Novel adeno-associated viral vectors for retinal gene therapy","volume":"19","author":"Vandenberghe","year":"2012","journal-title":"Gene Ther."},{"issue":"3","key":"10.1016\/j.exer.2024.109931_bib60","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nbt1073","article-title":"Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart","volume":"23","author":"Wang","year":"2005","journal-title":"Nat. Biotechnol."},{"issue":"20","key":"10.1016\/j.exer.2024.109931_bib61","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1523\/JNEUROSCI.0102-20.2020","article-title":"Mouse \u0393-synuclein promoter-mediated gene expression and editing in mammalian retinal ganglion cells","volume":"40","author":"Wang","year":"2020","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.exer.2024.109931_bib62","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/mthe.2000.0045","article-title":"Route of administration determines induction of T-cell-independent humoral responses to adeno-associated virus vectors","volume":"1","author":"Xiao","year":"2000","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.exer.2024.109931_bib63","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/laban0511-155","article-title":"Retro-orbital injections in mice","volume":"40","author":"Yardeni","year":"2011","journal-title":"Lab. Anim"},{"issue":"5","key":"10.1016\/j.exer.2024.109931_bib64","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1167\/iovs.10-6250","article-title":"Intravitreal injection of Aav2 transduces macaque inner retina","volume":"52","author":"Yin","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483524001520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483524001520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T21:37:15Z","timestamp":1719265035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483524001520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":64,"alternative-id":["S0014483524001520"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2024.109931","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficient retinal ganglion cells transduction by retro-orbital venous sinus injection of AAV-PHP.eB in mature mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2024.109931","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109931"}}